Literature DB >> 21283109

Antibody responses to glycolipid-borne carbohydrates require CD4+ T cells but not CD1 or NKT cells.

Dale Christiansen1, Hilary A Vaughan, Julie Milland, Julie Miland, Natalie Dodge, Effie Mouhtouris, Mark J Smyth, Dale I Godfrey, Mauro S Sandrin.   

Abstract

Naturally occurring anti-carbohydrate antibodies play a major role in both the innate and adaptive immune responses. To elicit an anti-carbohydrate immune response, glycoproteins can be processed to glycopeptides and presented by the classical antigen-presenting molecules, major histocompatibility complex (MHC) Class I and II. In contrast, much less is known about the mechanism(s) for anti-carbohydrate responses to glycolipids, although it is generally considered that the CD1 family of cell surface proteins presents glycolipids to T cells or natural killer T (NKT) cells. Using model carbohydrate systems (isogloboside 3 and B blood group antigen), we examined the anti-carbohydrate response on glycolipids using both antibody neutralisation and knockout mouse-based experiments. These studies showed that CD4(+) T cells were required to generate antibodies to the carbohydrates expressed on glycolipids, and unexpectedly, these antibody responses were CD1d and NKT cell independent. They also did not require peptide help. These data provide new insight into glycolipid antigen recognition by the immune system and indicate the existence of a previously unrecognised population of glycolipid antigen-specific, CD1-independent, CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21283109     DOI: 10.1038/icb.2010.166

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  6 in total

1.  Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.

Authors:  Patrick M Meyer Sauteur; Adrianus C J M de Bruijn; Catarina Graça; Anne P Tio-Gillen; Silvia C Estevão; Theo Hoogenboezem; Rudi W Hendriks; Christoph Berger; Bart C Jacobs; Annemarie M C van Rossum; Ruth Huizinga; Wendy W J Unger
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

2.  Blockade of invariant TCR-CD1d interaction specifically inhibits antibody production against blood group A carbohydrates.

Authors:  Hirofumi Tazawa; Toshimitsu Irei; Yuka Tanaka; Yuka Igarashi; Hirotaka Tashiro; Hideki Ohdan
Journal:  Blood       Date:  2013-08-13       Impact factor: 22.113

3.  Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity.

Authors:  Maja G Rydahl; Stjepan K Krac Un; Jonatan U Fangel; Gurvan Michel; Alexia Guillouzo; Sabine Génicot; Jozef Mravec; Jesper Harholt; Casper Wilkens; Mohammed Saddik Motawia; Birte Svensson; Olivier Tranquet; Marie-Christine Ralet; Bodil Jørgensen; David S Domozych; William G T Willats
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

Review 4.  CD1: A Singed Cat of the Three Antigen Presentation Systems.

Authors:  Radoslaw Kaczmarek; Mariola Pasciak; Katarzyna Szymczak-Kulus; Marcin Czerwinski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-04-06       Impact factor: 4.291

Review 5.  Expansion and Sub-Classification of T Cell-Dependent Antibody Responses to Encompass the Role of Innate-Like T Cells in Antibody Responses.

Authors:  Chanho Park; Tae Jin Kim
Journal:  Immune Netw       Date:  2018-10-23       Impact factor: 6.303

Review 6.  Tumor-Associated Glycans and Immune Surveillance.

Authors:  Behjatolah Monzavi-Karbassi; Anastas Pashov; Thomas Kieber-Emmons
Journal:  Vaccines (Basel)       Date:  2013-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.